CL2024002263A1 - Inhibidores peptídicos del receptor de interleucina-23 y composiciones farmacéuticas de los mismos. - Google Patents

Inhibidores peptídicos del receptor de interleucina-23 y composiciones farmacéuticas de los mismos.

Info

Publication number
CL2024002263A1
CL2024002263A1 CL2024002263A CL2024002263A CL2024002263A1 CL 2024002263 A1 CL2024002263 A1 CL 2024002263A1 CL 2024002263 A CL2024002263 A CL 2024002263A CL 2024002263 A CL2024002263 A CL 2024002263A CL 2024002263 A1 CL2024002263 A1 CL 2024002263A1
Authority
CL
Chile
Prior art keywords
interleukin
receptor
pharmaceutical compositions
peptide inhibitors
peptide
Prior art date
Application number
CL2024002263A
Other languages
English (en)
Spanish (es)
Inventor
Broeckx Geraldine
T Breslin David
Anduix Canto Clara
Paul De Dobbelaere Christopher
Deniau Gildas
Di Pretoro Giustino
Fernandes Philippe
Kolakovic Ruzica
Mertens Nathalie
Lomstein Pedersen Betty
Rajan Gopal
Sun Dajun
Patel Sejal
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CL2024002263A1 publication Critical patent/CL2024002263A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CL2024002263A 2022-02-01 2024-07-26 Inhibidores peptídicos del receptor de interleucina-23 y composiciones farmacéuticas de los mismos. CL2024002263A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202263305631P 2022-02-01 2022-02-01

Publications (1)

Publication Number Publication Date
CL2024002263A1 true CL2024002263A1 (es) 2025-02-07

Family

ID=85556753

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2024002263A CL2024002263A1 (es) 2022-02-01 2024-07-26 Inhibidores peptídicos del receptor de interleucina-23 y composiciones farmacéuticas de los mismos.

Country Status (13)

Country Link
EP (1) EP4472999A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025506374A (cg-RX-API-DMAC7.html)
KR (1) KR20240137102A (cg-RX-API-DMAC7.html)
CN (1) CN118829647A (cg-RX-API-DMAC7.html)
AU (1) AU2023215245A1 (cg-RX-API-DMAC7.html)
CA (1) CA3250172A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024002263A1 (cg-RX-API-DMAC7.html)
IL (1) IL314629A (cg-RX-API-DMAC7.html)
MX (1) MX2024009477A (cg-RX-API-DMAC7.html)
PE (1) PE20241895A1 (cg-RX-API-DMAC7.html)
TW (1) TW202342496A (cg-RX-API-DMAC7.html)
UY (1) UY40135A (cg-RX-API-DMAC7.html)
WO (1) WO2023150500A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250139359A (ko) 2023-01-31 2025-09-23 얀센 파마슈티카 엔브이 인터류킨-23 수용체의 결정질 펩티드 억제제의 제조 방법
EP4780453A1 (en) * 2023-09-21 2026-07-29 Janssen Pharmaceutica NV Interleukin-23 receptor antagonist for use in the treatment of ulcerative colitis
WO2025151385A1 (en) * 2024-01-08 2025-07-17 Janssen Pharmaceutica Nv Peptide inhibitors of interleukin-23 receptor and uses thereof
WO2025163534A1 (en) * 2024-01-31 2025-08-07 Janssen Pharmaceutica Nv Crystal form of a peptide inhibitor of interleukin-23 receptor
WO2025243217A1 (en) * 2024-05-22 2025-11-27 Janssen Pharmaceutica Nv Crystal forms of peptide molecules
WO2026106852A1 (en) * 2024-11-15 2026-05-21 Janssen Pharmaceutica Nv Methods of using interleukin-23 receptor antagonists
WO2026114760A1 (en) * 2024-11-29 2026-06-04 Zealand Pharma A/S Peptide inhibitors of interleukin-23 receptor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8946150B2 (en) 2011-06-14 2015-02-03 Medical Diagnostic Laboratories, LLC. Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
SMT202500254T1 (it) 2020-01-15 2025-09-12 Janssen Biotech Inc Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie

Also Published As

Publication number Publication date
UY40135A (es) 2023-08-31
KR20240137102A (ko) 2024-09-19
WO2023150500A1 (en) 2023-08-10
CN118829647A (zh) 2024-10-22
AU2023215245A1 (en) 2024-09-19
MX2024009477A (es) 2024-11-08
TW202342496A (zh) 2023-11-01
PE20241895A1 (es) 2024-09-19
EP4472999A1 (en) 2024-12-11
CA3250172A1 (en) 2023-08-10
JP2025506374A (ja) 2025-03-11
IL314629A (en) 2024-09-01

Similar Documents

Publication Publication Date Title
UY39857A (es) Inhibidores peptídicos lipidados del receptor de interleucina-23
UY39527A (es) Composiciones de los inhibidores de peptidos del receptor de interleucina-23
CL2024004039A1 (es) Péptido inhibidor monocíclico de un receptor de interleuquina-23; composición farmacéutica; y su uso.
AR126457A1 (es) Inhibidores peptídicos bicíclicos del receptor de interleuquina-23
MX2024000762A (es) Inhibidores peptidicos del receptor de interleucina-23.
AR119389A1 (es) Inhibidores de péptidos del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias
MX2024009477A (es) Inhibidores peptídicos del receptor de interleucina-23 y composiciones farmacéuticas de estos
MX2022008740A (es) Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias.
UY38221A (es) Inhibidores de proteínas ras con g12c mutantes
CL2023002223A1 (es) Inhibidores de cdk2 y métodos de uso de los mismos
CO2026004964A2 (es) Moduladores de kras
CO2021005140A2 (es) Formas mórficas de los inhibidores del factor d del complemento
CO2021004160A2 (es) Formas mórficas de los inhibidores del factor d del complemento
ECSP16071151A (es) Inhibidores de dihidropirrolopiridina de ror-gamma
MX2025001224A (es) Inhibidores de kit, compuestos, composiciones farmaceuticas y metodos de uso de los mismos
MX2025008922A (es) Metodos para preparar inhibidores peptidicos cristalinos del receptor de interleucina-23
UY40134A (es) Motor de presión negativa
CL2025002026A1 (es) Inhibidores peptídicos del receptor de interleucina-23 (il-23r)
DOP2025000151A (es) Inhibidores peptídicos del receptor de interleucina-23
UY38133A (es) Nuevos inhibidores de cdk8/19